Related Experiment Video
Updated: Jun 19, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease
Laura G Schuettpelz1, Deanna Behrens, Matthew I Goldsmith
1Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St Louis, MO 63110, USA. schuettpelz_l@kids.wustl.edu
Abstract:
Ceftriaxone-induced hemolytic anemia is a rare and often fatal phenomenon. We report here the case of a 6-year-old female with sickle cell disease who survived a brisk and profound hemolytic reaction, resulting in hemoglobin of 0.4 g/dL, after ceftriaxone infusion. Ongoing hemolysis was abrogated with aggressive supportive care, but the patient suffered extensive neurologic sequelae as a result of the event. Serologic testing confirmed the presence of ceftriaxone antibodies.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Rocky Mountain Spotted Fever
Hemorrhagic Stroke l: Introduction
